EVOME MEDICAL TECHNOLOGIES INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Evome Medical Technologies Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q4 2023.
  • Evome Medical Technologies Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2023 was 73.5M shares, a 33.2% increase year-over-year.
  • Evome Medical Technologies Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 73.5M shares.
  • Evome Medical Technologies Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 43.6M shares, a 29.1% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 73.5M +18.3M +33.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 78M +23.3M +42.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 73.9M +21.1M +39.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 62.4M +12.4M +24.7% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 55.1M +10.4M +23.1% Sep 1, 2022 Nov 30, 2022 10-Q 2023-01-17
Q3 2022 54.7M +10M +22.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 52.9M +17.9M +51.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 50M +16.2M +48% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 44.8M +11M +32.5% Sep 1, 2021 Nov 30, 2021 10-Q 2023-01-17
Q3 2021 44.7M -1.15M -2.51% Jun 1, 2021 Aug 31, 2021 10-Q 2022-10-17
Q2 2021 35M +1.21M +3.58% Mar 1, 2021 May 31, 2021 10-Q 2022-07-15
Q1 2021 33.8M Dec 1, 2020 Feb 28, 2021 10-K 2022-05-31
Q4 2020 33.8M Sep 1, 2020 Nov 30, 2020 10-Q 2022-01-14
Q3 2020 45.8M Jun 1, 2020 Aug 31, 2020 10-Q 2021-10-15
Q2 2020 33.8M Mar 1, 2020 May 31, 2020 10-Q/A 2021-08-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.